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Abstract 
Chronic infection of hepatitis virus B (HBV) is associated with an increased incidence of 
hepatocellular carcinoma (HCC). HBV encodes an oncoprotein (HBx) that is crucial for viral 
replication and interferes with multiple cellular activities including gene expression, histone 
modifications and genomic stability. To date, it remains unclear how disruption of these 
activities contributes to hepatocarcinogenesis. Here, we report that HBV exhibits a novel 
anti-resection activity by disrupting DNA end resection, thus impairing the initial steps of 
homologous recombination (HR). This anti-resection activity occurs in primary human 
hepatocytes (PHHs) undergoing a natural viral infection-replication cycle, as well as in cells 
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with integrated HBV genomes. Among the seven HBV-encoded proteins, we identified HBx 
as the sole viral factor that inhibits resection. By disrupting an evolutionarily conserved 
Cullin4A-DDB1-RING type of E3 ligase, CRL4WDR70, via its H-box, we show that HBx inhibits 
H2B monoubiquitylation at lysine 120 (uH2B) at double strand breaks, thus reducing the 
efficiency of long-range resection. We further show that directly impairing H2B 
monoubiquitylation elicited tumorigenesis upon engraftment of deficient cells in athymic 
mice, confirming that the impairment of CRL4WDR70 function by HBx is sufficient to promote 
carcinogenesis. Finally, we demonstrated that lack of H2B monoubiquitylation is manifest in 
human HBV-associated HCC (HBVHCC) when compared with HBV-free HCC, implying 
corresponding defects of epigenetic regulation and end resection. We conclude that the anti-
resection activity of HBx induces an HR defect and genome instability and contributes to 
tumorigenesis of host hepatocytes. 
 
 
Introduction 
Worldwide, chronic HBV infection and its associated diseases such as cirrhosis account for 
about 50% of all cases of human hepatocellular carcinoma (HCC) and the risk of 
carcinogenesis is elevated with increasing viral load (1, 2). The vast majority of the HBV-
associated hepatocellular carcinomas (HBVHCC) harbour chromosomally integrated HBV 
genomes (3, 4), although site-specific integration of the viral genome into known oncogene 
seems to be a rare event. This strongly suggests that HBV encodes a viral element that 
intrinsically promotes oncogenic transformation. During HBV infection, the small 3.2-Kb HBV 
genome expresses seven genes (preCore (HBeAg), Core, Pol, X, and three envelop 
proteins, L, M and S) for completion of the viral replication (5). The X gene encoding a 154-
residue pleiotropic transcriptional activator (HBx) serves as a stimulator of viral replication 
and gene expression (6, 7). A plethora of evidence suggests that HBx has the capacity to 
induce HCC in vivo, behaving as a prominent oncogenic driver for HBVHCC (8). However, 
the precise oncogenic targets and/or signal transduction pathways influenced by HBx remain 
enigmatic. 
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HBx lacks DNA binding activity and thus likely carries out its functions via protein-
protein interactions with cellular factors. One such HBx-interacting factor is DDB1, a core 
component of the Cullin-4 ring ligase (CRL4) family of ubiquitin ligases (9). The core of 
CRL4 complexes (CUL4-DDB1-ROC) is associated with a family of WD40 proteins, which 
act as substrate-targeting subunits and are known as DCAFs (10). Two short peptide 
stretches of DCAFs, the DWD (DDB1-binding WD40) and H-box motifs, are required for the 
docking of DCAFs to CRL4s via DDB1 (11-13). Intriguingly, the C-terminus of HBx 
resembles the H-box of a subset of cellular DCAFs (including DDB2 and DCAF9/WDTC1) 
and can selectively disengage DCAFs from CRL4 (12, 14). Recent studies have shown that 
HBx hijacks the E3 ligase activity of CRL4 to form viral CRL4HBx and remove specific cellular 
factors (i.e. SMC5/6) that are restrictive to viral replication (15).  
 
Impairment of the CRL4 core complex activitiy by tissue-specific knockout of DDB1 in 
hepatocytes has been shown to induce liver regeneration and tumorigenesis (16), 
suggesting a restriction of HCC by CRL4. This could be attributed to the potential of HBx to 
interfere with DNA damage responses: it compromises cell cycle checkpoint control by its 
interaction with p53 (9) and inhibits the UV light-induced nucleotide excision repair (NER) 
pathway by disrupting the CRL4DDB2 complex (17).  However, no role has been established 
for disabled NER in promoting human HBVHCC and removal of known DCAF factors do not 
account for the oncogenic activity of HBx. Thus, there exists a mechanistic gap in HBx-
triggered hepatocarcinogenesis, implying an uncharacterised mechanism underlying 
HBVHCC. 
 
Here, we present evidence that HBV infection inhibits DNA double strand break (DSB) 
repair in both HBV infected and HBV-integrated cells. We show that the disassembly of a 
recently identified CRL4 sub-complex, CRL4WDR70, by the HBx H-box motif compromises 
DNA end resection. The resulting loss of CRL4WDR70-dependent histone H2B 
monoubiquitylation prevents the association of RPA and RAD51 with DSBs and prevents 
efficient homologous recombination (HR) of DSBs. We demonstrate that the loss of WDR70 
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function phenocopies the impact of HBx on HR and establish that the epigenetic and repair 
defects caused by HBx can directly trigger tumorigenesis. Thus, this study provides 
compelling evidence that HBx possesses an anti-resection activity that inhibits CRL4WDR70-
mediated HR repair. These results in genome instability of host cells and potentially drives 
the carcinogenesis of HBVHCC. 
 
Experimental Procedures 
Cell lines 
L02, T43 (18), HepG2, HepG2.2.15, HEK293T and their derived cells were cultured in 
standard conditions. PHHs culture and infection with HBV were performed 
as described previously (19, 20). Additional details are in Supporting Materials. 
Biochemical, immunological and molecular assays 
Details of immunoassys, measurement of DNA damage responses, (RT-)qPCR and ChIP 
analysis are available in the supporting methods. 
Statistics 
All histograms were presented as means ± standard deviation. For quantitative analysis, 
including the ChIP assay and image analysis, at least three independent experiments each 
containing three parallel samples were performed. Statistical analysis between two groups 
was performed by t-test in GraphPad Prism 5: *, p<0.05; **, p, 0.01; ***, p<0.001; NS, no 
statistical significance. 
 
Results 
HBV infection induces a resection defect in host cells 
HBVHCC genomes are remarkably unstable ((21) and data not shown). We therefore 
examined whether HBV impacts on DSB repair, the malfunction of which often causes 
genome-wide structural variations. Congenic hepatocarcinoma cell lines (parental HepG2 
and derived HepG2.2.15 that harbours a functional HBV genome (22)) were challenged with 
DSB-generating agents and DSB responses were evaluation by indirect 
immunofluorescence. Upon camptothecin (CPT) treatment HepG2.2.15 cells, when 
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compared to control HepG2, showed reduced foci formation for NBS1 and RPA32, the latter 
of which is a replication protein A (RPA) subunit. RPA is a prominent marker for the ssDNA 
that arises from 5’-3’ DSB resection (23) (Supporting Fig.S1A). Phosphorylation of RPA32 
(pSerine 33 and pSerine 4/8) was also shown to be diminished by immunoblotting (Fig.1A 
and Supporting Fig.S1B). Since RPA constitutes a platform to attract HR factors onto 
processed DNA ends and is a prerequisite for HR (see Supporting Fig. S1C), these results 
suggest that DNA end resection, and consequently HR itself is compromised (24).  
 
To confirm that DSB resection is attenuated in HepG2.2.15 cells, single stranded DNA 
was visualised directly using BrdU incorporation and subsequent -BrdU antibody staining 
under non-denaturing conditions (Fig.1B). Because the generation of sufficient ssDNA from 
DNA end resection is required for the recruitment of Rad51 recombinase to mediate 
homology search and downstream HR events (25), we next visualised RAD51 foci. In 
HepG2.2.15 cells, the recruitment of RAD51 to DSBs after ionising radiation (IR) was 
dramatically decreased in comparison with HepG2 controls (Fig.1C). Thus, HBV is 
associated with resection and HR defects in a hepatocarcinoma cell line with integrated with 
viral genomes. 
 
Resection defect in HBV-infected cells 
Although HepG2.2.15 is a widely used as a model system for studying HBV replication, the 
hepatocarcinoma origin of this cell line and random integration of the viral genome may 
result in genetic variation of the host genome and therefore unfaithfully represent the cellular 
impact of HBV. To exclude this possibility and extend our observations to the circumstances 
of natural viral infection, we present two lines of evidence to establish that the HBV-induced 
resection and HR defects represent a generalised phenomenon. First, we show that the 
defects in RPA phosphorylation and RAD51 IRIF (ionising radiation-induced foci) hold true in 
an independently derived HBV-positive cell line (T43) that was generated by integrating viral 
genomes into normal hepatic L02 cells (18) (Fig.1D, F and Supporting Fig.S1D).  
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Second, we employed HBV infected primary hepatocyte cultures (PHHs) to investigate 
the impact of natural viral infection on resection activity (19, 20). The application of 
concentrated supernatants from HepG2.2.15 cells, or high-titre HBV patient serum, to PHHs 
resulted in efficient infection and viral replication as shown by increased HBsAg/HBeAg titres 
and the positivity for nucleocapsid antigen (HBcAg) during day 3-7 post-inoculation 
(Supporting Fig.S1E-F). As a consequence of HBV infection, IR-induced RPA32 
phosphorylation was reduced significantly in PHHs, coincidental with reduced 
RPA32/RAD51 IRIF in HBcAg-positive cells (Fig.1E-F). Taken together, these data 
demonstrate that DNA end resection is impeded during the course of HBV infection and 
maintained after integration of viral genomes. 
 
HBx counteracts CUL4A-DDB1-dependent resection via its H-box motif 
Genes involved in homology-dependent repair are frequently mutated in breast and ovarian 
cancer (26, 27). However, no human genetic abnormalities involving HR have been 
described for HBVHCC. To consolidate our observation that HBV-induced HR defects are 
directly attributable to a viral element, as opposed to genetic variation in the host genomes, 
we performed a screen for the impact of HBV viral genes on resection (Supporting Fig.S2A). 
By examining CPT-induced RPA and NBS1 phosphorylation, HBx was identified as the sole 
viral factor that renders cells defective in resection (Fig.2A and Supporting Fig.2B). HBx 
expression in L02 cells also perturbed RPA32 and RAD51 foci formation (Fig.2B and 
Supporting Fig.S2C). In corresponding experiments, we also showed that the defects in RPA 
phosphorylation and DSB loading were significantly restored in T43 cells upon silencing of 
HBx by siRNA (Fig.2C and Supporting Fig.S2D-E). siHBx could also rescue the defective 
IRIF of RPA and RAD51 in PHH cells (Supporting Fig.S2F). 
 
 
To exclude the possibility that overexpression of HBx produces off-target effects not 
seen in physiological conditions, mRNA levels of HBx in T43, HepG2.2.15 and PHHs were 
quantified (Supporting Fig.2G). T43 cells express HBx at a comparable level to infected 
PHHs,  but at significantly lower levels than that observed in HepG2.2.15. This likely reflects 
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the relative replicative activities, as indicated by the cccDNA copies (Supporting Fig.2H). 
Thus, we conclude that HBx confers HBV an anti-resection activity under physiological 
conditions. 
 
The majority of HBx protein is in a complex with DDB1 that is mediated by its H-box 
motif (residues 88-98) (28). This results in the re-direction of the CRL4 activity to support the 
viral life cycle (15, 29). We therefore tested the hypothesis that HBx interferes with resection 
by disrupting the function of CRL4 complexes. Indeed, the formation of RPA32 and RAD51 
IRIF was diminished upon DDB1 depletion by RNAi technology, indicating that a species of 
CRL4 complex that participates in regulating the formation of ssDNA filaments and resection 
is downregulated (Supporting Fig.S3A). CPT-induced phosphorylation of RPA32 / NBS1 
upon siDDB1 or siCUL4A treatment was also affected, resembling the phenotype of HBx 
expression (Supporting Fig.S3B-C). The similar HR defects caused by CRL4 ablation and 
HBx introduction suggest a possible mechanistic link between these factors in affecting DNA 
end resection. 
 
To elucidate how HBx impairs the resection process by interfering with CUL4A-DDB1, 
various mutants encompassing the H-box motif and the HBx carboxyl domain were 
constructed (Supporting Fig.S3D). Ectopic expression of these HBx mutants near or within 
the H-box (d3:C105-154Δ, Hdel: C88-100Δ and R96E) abolished the HBx-DDB1 association 
(Supporting Fig.S3E-G), consistent with a previous report (12). Interestingly, upon ectopic 
expression in L02 cells, abolition of the H-box impaired the anti-resection potential of HBx 
and the mutants displayed no profound impact on RPA32 phosphorylation or foci formation 
in contrast to HBx wild type (Fig. 2D-F). Therefore, we conclude that HBx via its H-box 
targets the function of CRL4 complex to impede DNA end resection. 
 
HBx interferes with CRL4WDR70-mediated DNA end resection 
To identify the CRL4 complex targeted by HBx in respect of end resection we examined the 
recently identified CRL4WDR70 complex that regulates resection in fission yeast (30). Similar 
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to the yeast homologue, WDR70 interacts with DDB1 (Supporting Fig.S4A). WDR70 protein 
contains a canonical DWD motif (residues 405-408 AA in the human homologue) as well as 
a conserved C-terminal H-box (653-662 AA) (Fig.3A-B). Both domains are indispensable in 
mediating the interaction of WDR70 with DDB1 (Fig.3C, (12, 30)). Strikingly, the C-terminus 
of WDR70 contains a similar feature to that characterised for DDB2 sequence: an additional 
α-helix adjunct to H-box that provides additional binding capacity between DDB1 and DDB2. 
The presence of this conserved additional -helix is predicated to provide extra binding 
capabilities for WDR70 and DDB1 (Fig.3B and Supporting Fig.S4B).  
 
The structural similarities between WDR70 and DDB2 suggest that WDR70 resembles 
the subclass of DCAF proteins (including DDB2) whose engagement to DDB1 via their H-
box is liable to competition by the homologous sequence of HBx (28). This would be 
consistent with the fact that knockout of human WDR70 by CRISPR in 293T cells (30) 
resulted in decreased NBS1/RPA32 phosphorylation and diminished RAD51 recruitment. If 
HBx is influencing HR mainly through an interaction with WDR70, we would predict that 
expressing HBx in WDR70 knockout cells would not further decrease NBS1 or RAP32 
phosphorylation. Indeed, when HBx was expressed in WDR70 knockout cells, there was no 
further decrease in NBS1 or RPA32 phosphorylation (Supporting Fig.S4C) following IR 
treatment and RPA plus RAD51 foci formation were also not decreased further (Fig.3D-E). 
This strongly suggests that the anti-resection activity of HBx can primarily be attributed to 
impairment of  CRL4WDR70 function. 
 
DSB repair is mainly mediated by two pathways, non-homologous end joining (NHEJ) 
and homologous recombination. NHEJ is active throughout the cell cycle while HR is 
restricted to the S/G2 phases due to the requirement for sister chromatid template (31). 
Therefore, a reduction of the S/G2 population could indirectly influence the observed 
resection efficiency without impairing HR machineries. However, FACS analysis showed 
only a modest <20% increase of G1 phase cells (with a corresponding decrease of S/G2 
phase) in WDR70 or DDB1 ablated cells. This could not account for the >50% reduction 
observed in IRIF and immunoblotting assays (Supporting Fig.S4D). Thus, the malfunction of 
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HR observed upon loss of WDR70 is primarily caused by inhibited end processing per se 
and not by cell cycle perturbation. We confirmed this was also the case in HBV containing 
cells by distinguishing G1 and S/G2 populations of T43 and HepG2.2.15 using the FUCCI 
system (Fluorescent ubiquitylation-based cell cycle indicator (32)). No apparent perturbation 
to the cell cycle distributions were observed (data not shown). Moreover, in WDR70 
knockout, T43 and HBx expressing cells, the reduction of RAD51/RPA32 IRIF was only 
apparent in Geminin-positive cells. Geminin staining specifically marks S/G2 cells (Fig.3F-
G). Thus, HBx interferes with the CRL4WDR70 complex and suppresses resection in S/G2. 
 
HBx inhibits resection by acting as a dominant negative for the assembly of 
CRL4WDR70 
To test our hypothesis that HBx can engage with DDB1 via its H-box and consequently 
displaces WDR70 from the CRL4 scaffold we examine the impact of HBx on CRL4WDR70 
complex integrity. As predicted, the binding of WDR70 to DDB1 was effectively competed by 
HBx expressed from either lentivirus (Fig.4A) or at low level expression from integrated HBV 
genomes (T43) (Fig.4B and Supporting Fig.S5A-B). The attenuation of the DDB1-WDR70 
interaction in T43 cells could be effectively reversed by ablating HBx with siRNA (Fig.4C). 
Moreover, both DDB1 or WDR70 over-expression overrode the reduction of RPA32 
phosphorylation in T43 and HBx-expressing L02 cells (Fig.4D). These data strongly indicate 
HBx, even at relatively low levels of expression, disrupts the formation of the CRL4WDR70 
complex. 
 
It is likely that the HR defect observed when HBx is expressed results from loss of the 
CRL4WDR70 complex, since we have shown that expressing HBx in WDR70 knockout cells 
did not exacerbate the HR phenotype (Fig 3D,E). None the less, it is possible that, because 
HBx forms a viral CRL4 complex and re-directs the ubiquitin ligase activity to decrease the 
levels of specific cellular proteins (15), HBx could induce HR defects directly, for example by 
degrading a key HR protein (11, 33). To further address this possibility, SV5-V, a protein 
encoded by a paramyxovirus (Simian virus 5) that shares a homologous H-box with HBx (33) 
(Supporting Fig.S5C), was employed. 
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Apart from their similar ability to bind DDB1, the amino acid sequence and functions of 
SV5 V protein and HBx are unique and cannot substitute for each other in terms of viral-host 
interaction. We reasoned that, if HBx forms a novel CRL4 E3 ligase to target a HR protein, 
SV5 V protein will not be able to substitute for HBx in terms of its inhibition of resection. 
Interestingly, we observed a clear impact of SV5 V protein on RPA phosphorylation (Fig.4E) 
and on the assembly of the of CRL4WDR70 complex, equivalent to that seen for HBx (Fig.4F). 
This corroborates that viral H-boxes, regardless of their origin, are sufficient to disrupt 
CRL4WDR70-dependent resection. It also strongly argues against the possibility that HBx 
reconstitutes the CRL4 ubiquitin ligase activity to target a repair protein that is key for 
resection. We therefore conclude that HBx directly blocks the assembly of CRL4WDR70 and 
that this, rather than the reprogramming the CRL4 activity, is the cause of the HR defects we 
observe. 
 
Reduction of CRL4WDR70-dependent H2B monoubiquitylation in the presence of HBx 
DNA lesions are repaired in the context of chromatin and the compact nucleosomal structure 
needs to be remodelled to allow damaged DNA to become accessible to repair factors (34-
36). Give the role of yeast CRL4Wdr70 in coordinating DSB repair and histone modification 
(30), we investigated a variety of histone modifications under the condition of HBx 
expression and CRL4WDR70 depletion and in HepG2.2.15 cells. Notably, levels of H2B 
monoubiquitylation (K120) and multiple forms of methylated H3K4 and H3K9 were reduced 
in when HBx was present (Fig.5A-C and Supporting Fig.S6A). Again, natural HBV infection 
in PHHs and ectopic expression of SV5-V also strongly decreased H2B modification at K120 
(Fig.5D and Supporting Fig.S6B).  
 
H2B monoubiquitylation is required for the timely repair of DSBs and malfunction of this 
pathway is implicated in tumorigenesis (37, 38). Similar to the impact of HBx-expression and 
WDR70 depletion, the introduction of non-ubiquitylatable H2B (2KR: K120R/K125R) into L02 
cells prevented RPA32 chromatin association (Fig.5E). This is consistent with H2B 
monoubiquitylation being required for resection. We could again link this defect directly to 
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CRL4WDR70 since the deficiency in H2B monoubiquitylation observed in T43 and HBx 
expressing L02 cells could be complemented by WDR70 expression, congruent with the 
rescue of RPA phosphorylation (Fig.5F and Supporting Fig.S6C). In addition, ablation of HBx 
by siRNA in T43 cells also restored the level of uH2B (Fig.S6D). Furthermore, ablating the 
components of HULCRNF20, the ubiquitin ligase for H2B monoubiquitylation (39), inhibited 
RPA phosphorylation as well as the foci formation of RPA32 and RAD51, which again 
displayed epistasis with WDR70 depletion (Supporting Fig.S6E-G). These results 
consolidate the notion that the anti-HR effect of HBx is exerted through chromatin 
remodeling events co-regulated by HULCRNF20 and CRL4WDR70. 
 
HBx impedes extensive H2B monoubiquitylation and long-range resection 
To demonstrate that the perturbation of CRL4WDR70-dependent H2B monoubiquitylation by 
HBx occurs at the chromatin level, we employed ChIP assays (chromatin 
immunoprecipitation) to characterise the chromatin dynamics at Intron 1 of the 
PPP1R12C/p84 gene (Fig.6A). When DSBs were artificially induced by CRISPR-gRNA at 
this locus, the enrichment of H2B monoubiquitylation at regions surrounding an induced 
DSBs was weakened upon WDR70 knockout or in the presence of HBV/HBx (Fig.6B). 
Intriguingly, the presence of HBx or the loss of WDR70 markedly impaired the enrichment of 
H2B monoubiquitylation at regions distal to DNA breaks (>3.5 Kb) but exerted no detectable 
impacts in the proximal regions tested (0.5 Kb and 3.5 Kb). In concordance with the impact 
of HBx on CRL4WDR70 complex integrity, this regional effect was correlated with the ability of 
HBx to exclude the loading of DDB1 and WDR70 from distal chromatin domains of DSBs 
(data not shown). Thus, HBx disables an evolutionarily conserved role of CRL4WDR70 in 
expanding the H2B monoubiquitylation towards DSB-distal regions. 
 
The progression of resection is catalysed by the cooperation of several enzymes: CtIP 
and the MRN nuclease initiate resection to generate a short ssDNA substrate. This is 
subsequently extended by EXO1 and BLMRqh1-DNA2, channeling repair into the HR 
pathways (40). To dissect how HBx influences the chromatin loading of resection factors via 
down-regulation of H2B monoubiquitylation, patterns of chromatin recruitment for a variety of 
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repair factors were analysed by ChIP assays using the CRISPR-induced DSB assay. 
Strikingly, we detected a reduction of RPA32 recruitment at 10 Kb and 50 Kb from the DSB 
site in the presence of HBx or following the loss of WDR70 (Fig.6C). This suggests that the 
failed extension of H2B modification to the DSB-distal prevents long-range resection. 
Indeed, introduction of a non-ubiquitylatable 2KR mutant of H2B into L02 cells reduced the 
RPA32 loading, replicating the defect caused by HBx and WDR70 depletion (Fig.6D). 
Consistent to the resection defects monitored by RPA loading, the chromatin association of 
the long-range resection nuclease (EXO1) displayed a dramatic decrease exclusively at 
sites distal to the DSB upon depletion of WDR70 or HBx expression. No alteration of DSB-
enrichment of the resection initiator (MRE11) was detected in the same set of experiment 
(Fig.6E-F). Therefore, HBx induces CRL4WDR70 disruption and this results in a reduction of 
H2B monoubiquitylation and specifically prevents the chromatin loading of EXO1 and the 
ensuing extensive resection. 
 
Defective H2B monoubiquitylation promotes tumorigenesis 
We have shown that HBx ablates the CRL4WDR70 complex and that this results in a resection 
defect. The first observed event we see when CRL4WDR70 is defective is a failure of H2B 
monoubiquitylation. To investigate if CRL4WDR70-dependent H2B monoubiquitylation could 
contribute to tumour suppression, a stable cell line of L02 integrated with a lenti-viral 2KR 
construct was established. Two million cells were then injected subcutaneously into immune 
defective athymic nude mice and tumour growth was monitored. The 2KR-expressing L02 
cells exhibited uncontrolled neoplastic proliferation when compared with control cells. 
Remarkably, co-expression of WDR70 and DDB1 genes suppressed this increased 
tumorigenesis (Fig.7A). Consistent with H2B monoubiquitylation acting in a tumour 
suppressor pathway, over-expression of the de-ubiquitinase USP22 (which eliminates H2B 
monoubiquitylation), also significantly promoted tumour growth (Fig.7B).  
 
We also generated HBV-positive xenograft models by embedding L02 and T43 cells in 
nude mice. Resembling the 2KR inoculums, T43 but not L02 inoculums resulted in 
aggressive tumour outgrowth (Fig.7C) that could be significantly repressed by 
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overexpression of DDB1 or WDR70 or by in vivo knockdown with siHBx (Fig.7D and 
Supporting Figure S7A). Examination of these tumours by immunohistochemical staining 
revealed that H2B monoubiquitylation was absent in T43-derived xenografts (Fig.7E). Taken 
together, these data support the idea that the CRL4WDR70-H2B signalling pathway acts as a 
crucial anti-cancer mechanism, inhibition of which by HBx potentially promotes 
tumorigenesis. 
 
Implication of the HBx-mediated anti-resection activity in human HBVHCC 
As HBx is expressed in significant proportion of human HBVHCC, H2B monoubiquitylation, 
whose levels are correlated to the function of CRL4WDR70-mediated resection, could serve as 
the predictive marker of HR status. We therefore examined H2B monoubiquiination in 
clinically isolated liver cancer tissues. Paraffin-embedded sections of cohorts of either HBV-
positive or HBV-negative-HCC biopsies were subjected to immunohistochemical (IHC) 
staining with antibody specific to ubiquityl H2B (K120) (Fig.8A). In comparison to HCC 
samples that were negative for serological HBV surface antigen (HBs), sections from 
HBVHCC patients displayed a statistically lower intensity and percentage of uH2B when 
visualized by staining of -uH2B (Fig.8B). A small proportion of HBVHCC displayed modest 
level of H2B monoubiquitylation, possibly due to occult infection (41) or an acquired second 
mutation such as 53BP1, which can potentially rescue HBx-induced HR defect. Similarly, 
uH2B levels in HBV-negative non-HCC tissues are also significantly higher than those of 
HBV-positive (Fig.8B and Supporting Fig.S7B). Thus, given the mechanistic link between 
HBx and CRL4WDR70-mediated H2B monoubiquitylation, a reduction of uH2B levels in the 
majority of HBVHCC tissues can be potentially correlated with the anti-resection-activity of 
HBx. 
 
Genetic variants of the HBx gene, such as missense mutations at residuals 5, 130 and 
131, emerge during the course of HBV-associated liver diseases and finally prevail in late-
stage HCC (42). These mutant forms, especial those locating in the C-terminus of HBx (130 
and 131), could potentially disable the capability of HBx to block end resection. However, we 
found these clinically prevalent HBx mutants largely preserved the suppressive effect on 
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resection: none of these variants reduced the ability of HBx to suppress H2B 
monoubiquitylation or RPA32 and NBS1 phosphorylation (Fig.8C). This result correlates with 
the IHC assays that demonstrated diminished H2B monoubiquitylation in the majority of 
HBVHCC biopsies (Fig. 8A). Thus, despite the prevalence of mutations in late stages of 
HBVHCC, HBx maintains the potential to influence epigenetic regulation and end resection. 
 
Discussion 
HBx is the oncoprotein of HBV and is tightly linked to the progression of HBVHCC. HBx 
transcripts and protein can be detected in hepatocytes from 70% of chronically infected 
patients and in many HBVHCC biopsies (43, 44). However, how HBV and HBx promote liver 
cancer is not adequately understood. Here, we report for the first time that HBV impedes an 
early step of homologous recombination. We demonstrate that, via the HBx protein, HBV 
interferes with DNA end resection and HR repair. This occurs during both phases of acute 
infection (PHHs) and integration in the host genome (HepaG2.2.15 and T43). These data 
demonstrate that the HBx-mediated anti-resection activity is a genuine viral impact on host 
cells, as opposed to an artificial phenomena caused by random viral integration. Equally 
importantly, our analysis establishes that the integration of HBV fragments can cause long-
term effect on genome stability: as long as viral replication is active, or the HBx is expressed 
(even at relatively low levels) during any stage of the disease (chronic infection, cirrhosis and 
hepatocarcinoma), resection and thus HR would be restrained. This can potentially render 
host genomes genetically unstable over extended periods of time (Fig.8D).  
 
HBx disassembles specific CRL4 sub-complexes or retargets the CRL4 to support the 
viral life cycle (12, 15). A subset of DCAFs, including WDR70, is strongly dissociated from 
DDB1 in the presence of HBx. Our sequence alignment of the H-boxes of HBx and several 
DCAFs identified residues important for the DDB1 interaction (Fig.3A). Interestingly, WDR70 
and DDB2 share C-terminal sequences that fold into successive α-helices and provide 
additional surfaces that bind to DDB1 (Fig.3B and Fig.S4B). Upon direct competition from 
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HBx, this additional binding is likely to be disrupted, leading to the dissociation of WDR70 
from the CRL4 scaffold.  
 
Our data establishes a functional link between HBx and CRL4-mediated DNA end 
resection based on the competition between HBx and WDR70 for DDB1 binding. We 
identified that it is the ablation of the CRL4WDR70 subcomplex that is responsible for the HR 
defect in HBV-infected or HBV-integrated cells. We can rule out the possibility that HBx 
causes the HR defect through hijacking and reprogramming the ubiquitin ligase activity of 
CRL4s towards proteins required for resection for two reasons. First, expression of HBx 
does not further decrease the resection defects observed in WDR70 knock out cells. 
Second, the anti-resection activity of HBx is entirely dependent on its H-box motif and the 
introduction of the SV5 H-box peptide is fully capable of disrupting CRL4WDR70 complex 
integrity and subsequent HR events. These data directly link HBV-mediated HR interference 
to the structural integrity of CRL4 complexes. Therefore, impact of HBx on DDB1 results in 
two major HBV-related pathologies: by forming a viral CRL4HBx ubiquitin ligase, HBx 
promotes viral replication by targeting SMC5/6 for proteasome-dependent ubiqutiniation 
(45). In this case, CRL4 ubiquitination activity is obligatory for viral replication. Independent 
of CRL4HBx activities, HBx also exerts an anti-resection activity by blocking CRL4WDR70 
complex formation, which causes genome instability in host cells (data not shown). The 
complex influence of HBx on the CUL4-DDB1-related complexes shed lights on future drug 
design: for example. small molecules could be identified as anti-viral compounds, which 
prevent the DDB1-HBx interaction and/or restore the integrity of CRL4WDR70. 
 
In the context of HBV induced carcinogenesis, we show that loss of CRL4WDR70 
phenocopies HBV infection and HBx expression and has the potential to drive the oncogenic 
transformation by promoting genome instability. Ablation of WDR70 caused an equivalent 
decrease of uH2B and DSB-recruitment of RPA/RAD51 as is seen during HBV infection and 
post-integration stage. Resembling the well-established model of breast cancer inflicted by 
BRCA1 mutation (46, 47), a reduction of HR upon HBV infection predictes a threat to 
genome stability and render host cells susceptible to oncogenic transformation. We further 
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support the prediction that HBV promotes carcinogenesis by interfering with CRL4WDR70 by 
showing that the ablation of H2B  ubiquitylation (by expressing a 2KR mutant) dramatically 
promoted oncogenic proliferation and that this could be effectively suppressed by 
concomitant over-expression of WDR70. Again this correlates well with the observation that 
the aggressive growth driven by HBV in T43 cells was accompanied by low level of uH2B in 
comparison to control cells. Therefore we conclude that the CRL4WDR70-uH2B regulatory 
network is a novel anti-cancer mechanism and meets the criteria being a direct oncogenic 
target of HBx.  
 
HBx is the crucial factor for HBV replication and antigen expression. This poses the 
question as to whether the modulation of resection benefits the viral replication. In previous 
work we showed that ablating of DDB1 inhibited viral production and gene expression of 
HBV, indicating that DDB1 is required for viral production (18). Our preliminary data also 
suggest that loss of WDR70 facilitates viral replication (data not shown). There could be 
several putative mechanisms by which CRL4WDR70 and H2B monoubiquitylation influence 
HBV replication: aberrant DNA structures (i.e. hairpins or single-stranded DNA) are formed 
during HBV replication and anti-viral mechanisms are likely to be activated in response to 
these potential signatures of viral infection. In such a scenario, a reduction of CRL4WDR70-
uH2B activity may be advantageous to curb unwanted processing of intermediate structures 
by host nuclease (such as BLM and EXO1). Alternatively, it is likely that  CRL4WDR70 is 
involved in regulating viral gene expression through modulating the levels of H2B 
monoubiquitylation in promoter regions (data not shown). Therefore, from the perspective of 
viral replication, HBx may facilitate viral gene expression and protect viral genomes by 
influencing histone modifications, transcription and host nucleases.  
 
Taken together, our findings reveal that HBx interferes with the CRL4WDR70-mediated 
DNA end resection and causes HR deficiency in HBV-infected hepatocytes. Impaired DSB 
repair contributes to genome instability and drive hepatocarcinogenesis.  
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Figures legends 
Fig.1. HBV attenuates DNA end resection upon genotoxic insults. (A) Immunoblotting for 
RPA32 phosphorylation in HepG2 and HepG2.2.15 cells upon CPT treatment. pRPA32: 
phosphorylated Serine33 of RPA32. Asterisk: band shift of phosphorylated RPA32 detected 
by -RPA32 serum. (B) Non-(-HCl) and denaturing-(+HCl) indirect immunofluorescence (IF) 
showing ssDNA at resected DSBs and equal incorporation of BrdU after CPT treatment, 
respectively. Scale bar: 40 microns. (C) Representative image and percentage of RAD51 
IRIF-positive cells after 5-Gy irradiation in HepG2 and HepG2.2.15 cells. (D) Representative 
images for IRIF of RAD51and phosphorylated RPA32 (pSerine 33) in L02 and T43 cells after 
IR treatment. (E) Images (top) and quantification (bottom) of indicated IRIF in mock or HBV-
infected PHHs at day 7. Cells were fixed for immunostaining 4 hours after 1 Gy irradiation. 
HBcAg (green) marks HBV-infected PHHs. (F) Immunoblotting for RPA32 phosphorylation in 
L02/T43 cells or HBV-infected PHHs at indicated times. genotoxic treatments: 2 uM CPT or 
5 Gy irradiation.  
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Fig.2. HBx impairs DNA end resection. (A) Immunoblotting for IR or CPT-induced RPA32 
and NBS1 phosphorylation in the presence, or not, of HBx. L02 cells were pre-infected with 
2 MOI/cell of pLV (mock infection) or pLV-HA-HBx lentivirus. (B) pLV or pLV-HBx transfected 
L02 cells were treated as in A, followed by immunostaining of RAD51 and pRPA32 foci. (C) 
Monitoring of RPA32 phosphorylation in indicated cells treated, or not, with siHBX. (D) 
Immunoblotting for pRPA32 in CPT-treated L02 cells transfected with indicated expression 
plasmids. HBx and Hdel (HBx with H-box deleted: AA88-98) were monitored by -HA. (E) 
Percentage of pRPA32 IRIF-positive L02 cells pre-transfected with different HA-HBx 
constructs. pRPA32 foci were monitored 4 hours after irradiation. Cells with double positive 
staining of HA and pSerine 33 were judged as positive except in ‘HBx-’ cells (no HA-HBx 
transfection) where pRPA32 were counted in random cells. Insert: co-staining of HA-HBx 
(green) and pSerine 33 (red). n = 3 biological repeats. Error bars = s.d. (F) IF for pRPA32 in 
L02 cells infected with HBx wild type or R96E lentivirus (2 MOI/cell) followed by IR 
treatment.  
 
Fig.3. Disruption of CRL4WDR70 complex by HBx results in a resection defect. (A) Sequence 
alignment for the H-boxes of cellular DCAF proteins and HBx (WDTC1: alias of DCAF9). 
Red triangle: binding hotspots serving as key DDB1-contacting residues. (B) By sequence 
alignment and secondary structure prediction, the WDR70 C-terminal sequence possesses 
similar H-box sequence and an adjunct α-helical structure to that of DDB2, indicating their 
similar docking mode to DDB1. (C) IP of endogenous DDB1 in 293T cells by Flag-tagged 
WDR70 with or without H-boxes (653-662 AA). V: empty vector; Hdel: H-box deletion mutant 
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of WDR70. (D) IF staining for phosphorylated RPA32 or RAD51 IRIF in parental and WDR70 
knockout (70KO) 293T cells with or without HBx expression. IRIF defects in 70KO cells were 
not exacerbated by the presence of HBx. (E) Quantification for IRIF as in (D). n = 3 
biological repeats. Error bars = s.d. NS: no significant difference. (F, G) Representative 
images and quantification for RAD51 (F) and pRPA32 (G) foci in IR-treated cells (4 Gy). 
Geminin-GFP represents S/G2 cells. 
 
Fig.4. HBx influences CRL4WDR70-dependent end resection via its H-box. (A) 
Immunoprecipitation of endogenous DDB1 by Flag-WDR70 in the presence, or not, of over-
expressed HBx. Flag-WDR70 plasmid was transfected into L02 cells 24 hours before 
infection by pLV-HA-HBx lentivirus. Cells were lysed for co-IP analysis 48 hours after 
infection. -WDR70 and -DDB1 were used to detected individual proteins. (B) 
Immunoprecipitation of endogenous DDB1 by Flag-WDR70 in L02 and T43 cells. (C) 
Rescue of DDB1-WDR70 interaction in T43 cells by introducing siHBx. (D) Restoration of IR-
induced pRPA32 by forced expression of DDB1 or Flag-WDR70 in HBx expressing L02 
cells. Note that the protein level of HBx is elevated upon DDB1 over-expression, possibly 
due to a stabilising effect of their interaction (29). (E, F) Decreased RPA32 phosphorylation 
(E) and interaction between endogenous Flag-WDR70 and DDB1 (F) in L02 cells in the 
presence of HA-tagged SV5-V serving as an H-box surrogate for HBx. 
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Fig.5. HBx inhibits damage-induced H2B monoubiquitylation. (A-D) Evaluation of damage-
induced H2B monoubiquitylation in HBx-expressing L02 cells (A), WDR70-(B) or DDB1-(C) 
depleted 293T cells and in PHHs with HBV replication (D). The densitometry of uH2B was 
determined relative to corresponding loading controls. H2B: loading control. (E) 
Immunoblotting for chromatin fractions of RPA32 probed with -RAP32 serum in L02 cells 
with indicated treatments. Cells were treated with 2 uM CPT for 2 hours. H3: histone H3 
level as loading control. (F) Partial restoration of H2B monoubiquitylation levels by over-
expression of pLV-Flag-WDR70 in HBx expressing L02 (E). W+H: co-expression of Flag-
WDR70 with HBx.  
 
Fig.6. HBx impairs CRL4WDR70-mediated extensive monoubiquitylation of H2B in the vicinity 
of DSBs. (A) Schematic representation for CRISPR-gRNA-DSB at human PPP1R12C/p84 
locus of chromosome 19. The gRNA targeting sequence in Intron 1 is highlighted in green. 
Upon transfection, CRISPR-RNA complexes digest DNA within a range of 100 bp 
downstream of the recognition site. Arrows, primer sets across cutting site; black bars, PCR 
amplicons for ChIP assays. The size of individual amplicons are 171 bp (0.5 Kb), 169 bp (3.5 
Kb), 168 bp (10 Kb) and 162 bp (50 Kb), respectively. See also Supporting Fig. S7A-B. (B) 
Enrichment of H2B monoubiquitylation assayed by ChIP in HBx-expressing and WDR70 
knockout 293 cells, or in L02 and T43 cells. Distances from PPP1R12C/p84-
specificCRISPR-gRNA (g1) induced DSBs were indicated at left. g0: control gRNA plasmid 
expressing no targeting sequence. (C, D) DSB-loading of RPA32 assayed by ChIP in 
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indicated cells and distance from breakpoint. (E, F) Chromatin loading of EXO1 (E) and 
MRE11 (F) assayed by ChIP in HBx-expressing and WDR70 knockout 293T cells.  
 
Fig.7. Loss of H2B monoubiquitylation promotes tumorigenesis. (A) Subcutaneous xenograft 
of L02 cells pre-infected by indicated lentivirus. Note the suppression of tumorigenesis of 
2KR by co-expression of DDB1 or WDR70. (B) Immunoblotting for H2B monoubiquitylation 
in L02 cells by over-expression of human USP22 (left). Cells expressing USP22 were 
inoculated in nude mice and measured for tumor formation (right). (C) Xenograft tumor 
formation assay in nude mice. Individual tumor samples were dissected from nude nice 10 
days after subcutaneous injection of L02 or T43 cells (left) and average tumor weight (right) 
were calculated. n = 9 dissected samples. Error bars: s.d. ** = p<0.01. (D) As in C, tumor 
formation assays for T43 cells pre-infected with pLV-vector, pLV-DDB1 or pLV-WDR70 
lentivirus. (E) IHC images (inset) and quantification of uH2B positivity for paraffin-embedded 
xenografts. Nuclei were counterstained by hematoxylin (blue). n = 10 dissected samples. 
 
Fig.8. Implication of H2B monoubiquitylation and resection defects in human HBVHCC. (A) 
Comparison of H2B monoubiquitylation by IHC in hepatocarcinoma with or without HBV 
infection. HBV carriers were diagnosed according to the ELISA test for serological positivity 
of surface antigen. HD/MD/PD: highly, moderately and poorly differentiated HCC. (B) 
Quantitative analysis by IRS for immunohistochemical staining of uH2B in HCC and non-
HCC samples, see also Supplemental Methods. P=0.0057. (C) Impact on RPA32 
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phosphorylation and H2B monoubiquitylation in L02 cells by wild type and three clinically 
prevalent mutants of HBx at residuals 5, 130 and 131. None of the single, double or triple 
combination of mutations significantly diminishes the inhibitory effects of HBx on these 
cellular activities. (D) Model for the anti-resection activity of HBx on HR through CRL4WDR70-
dependent chromatin modification. Mirroring the deletion of yeast Wdr70, HBx dissembles 
the functional CRL4WDR70 complex and results in decreased H2B monoubiquitylation, leading 
to an aberrant chromatin landscape. HBx impairs long-range resection. The resultant loss of 
homologous recombination promotes genome instability and thus provides a driver for the 
HBV-associated carcinogenesis.  
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